Stockreport

Pharvaris Provides Business Update and Expands Development Program for Deucrictibant [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF Differentiated deucrictibant profile, including long-term extension results, to be highlighted in clinical, real-world, nonclinical, and discovery data presentations at [Read more]